Agios to Present Data From the Phase 3 ClarIDHy Study of TIBSOVO® in Previously Treated IDH1 Mutant Cholangiocarcinoma in Presidential Symposium at ESMO

September 10, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search